UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 | FORM 10-Q | | --- | | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ☒ | | OF 1934 | | For the quarterly period ended June 30, 2025 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT | | ☐ OF 1934 | | For the transition period from to | | Commission file number: 001-38704 | | HUDSON GLOBAL, INC. | | (Exact name of registrant as specified in its charter) | | Delawar ...

Hudson Global (HSON) Q2 2025 Earnings Call August 08, 2025 10:00 AM ET Speaker0Good morning, and welcome to the Hudson Global Conference Call for the 2025. Our call today will be led by Chief Executive Officer, Jeff Eberwein Chief Financial Officer, Matt Diamond and Global CEO of Hudson RPO, Jake Zapkowitz. Please be advised that the statements made during the presentation include forward looking statements under applicable securities laws. Such forward looking statements involve certain risks and uncertain ...

Hudson Global (HSON) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -29.41%. A quarter ago, it was expected that this staffing company would post earnings of $0.06 per share when it actually produced a loss of $0.46, delivering a surprise of -866.67%.Over the last four quarters, the ...

Q2 2025 Earnings Call A u g u s t 8 , 2 0 2 5 Forward-Looking Statements This presentation contains statements that the Company believes to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future f ...

Exhibit 99.1 Jeff Eberwein, CEO of Hudson Global, added, "As Jake referenced, we continue to make investments in our business to better support our clients' recruitment needs and streamline operations. Altogether in the first half of 2025, we invested approximately $1.4 million in sales, marketing, and technology above maintenance levels to enhance future growth. Our growth strategy remains focused on organic expansion, targeted bolt-on acquisitions, and cross-regional service integration initiatives design ...

OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON) ("Hudson Global" or "the Company"), a leading global total talent solutions company, announced today financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Summary Revenue of $35.5 million decreased 0.5% from the second quarter of 2024 and 0.2% in constant currency.Adjusted net revenue of $18.6 million increased 5.8% from the second quarter of 2024 and 5.1% in constant currency.Net loss was ...

OLD GREENWICH, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (the “Company” or “Hudson RPO”) (Nasdaq: HSON), a leading global total talent solutions company, announced today the strategic integration of McKinsey CMO Group (“CMRG”), a boutique firm specializing in recruitment marketing, brand strategy, and talent engagement. The addition of CMRG’s expertise will enable Hudson RPO to further support clients in building stronger employer brands, elevating candidate experiences, and attracting to ...

Group 1 - Halper Sadeh LLC is investigating Foot Locker, Inc. for potential violations related to its sale to DICK'S Sporting Goods, where shareholders can choose between $24.00 in cash or 0.1168 shares of DICK'S common stock for each share of Foot Locker [1] - Enzo Biochem, Inc. is being sold to Battery Ventures for $0.70 per share in cash [2] - Hudson Global, Inc. is merging with Star Equity Holdings, Inc., resulting in Hudson shareholders owning approximately 79% of the combined company post-transaction [2] Group 2 - Halper Sadeh LLC may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [3] - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Group 1: Foot Locker, Inc. Merger - Foot Locker, Inc. is investigating a proposed merger with DICK'S Sporting Goods, Inc., where shareholders can choose to receive either $24.00 in cash or 0.1168 shares of DICK'S common stock for each share of Foot Locker common stock [1] - The shareholder vote for the merger is scheduled for August 22, 2025 [1] Group 2: Enzo Biochem, Inc. Sale - Enzo Biochem, Inc. is set to be sold to Battery Ventures for $0.70 per share in cash without interest to shareholders [2] - The shareholder vote for this transaction is scheduled for August 19, 2025 [2] Group 3: Hudson Global, Inc. Merger - Hudson Global, Inc. is involved in a merger with Star Equity Holdings, Inc., where Hudson shareholders will own approximately 79% of the combined company post-transaction [2] - The shareholder vote for this merger is scheduled for August 21, 2025 [2] Group 4: Breeze Holdings Acquisition Corp. Merger - Breeze Holdings Acquisition Corp. is proposing a merger with YD Biopharma Limited, where all ordinary shares of Breeze Holdings will convert into the right to receive one ordinary share of the surviving company [3] - The shareholder vote for this merger is scheduled for August 14, 2025 [3]

Group 1 - Class Action Attorney Juan Monteverde's firm has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - CARGO Therapeutics, Inc. is being investigated regarding its sale to Concentra Biosciences, LLC for $4.379 in cash per share, plus contingent value rights related to net cash and proceeds from specific therapies [1] - Hudson Global, Inc. is merging with Star Equity Holdings, Inc., with Hudson shareholders expected to own approximately 79% of the combined company post-transaction [1] - Breeze Holdings Acquisition Corp. is proposed to merge with YD Biopharma Limited, converting all ordinary shares into the right to receive shares of the surviving company [2] - Enzo Biochem, Inc. is selling to Battery Ventures for $0.70 per share in cash, with a shareholder vote scheduled for August 19, 2025 [3] Group 2 - Monteverde & Associates PC is a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court [4] - The firm emphasizes that no company, director, or officer is above the law, encouraging shareholders with concerns to reach out for additional information [5]